Loading…

A novel approach in the management of right-sided endocarditis: percutaneous vegectomy using the AngioVac cannula

The AngioVac is a vacuum-based device introduced in 2012 to percutaneously remove undesirable material from the intravascular system. In scattered reports, the AngioVac has been used for removal of device-led vegetations and right-sided thrombi. In this article, we describe three cases of right-side...

Full description

Saved in:
Bibliographic Details
Published in:Future cardiology 2017-05, Vol.13 (3), p.211-217
Main Authors: Thiagaraj, Ashwin K, Malviya, Meenal, Htun, Wah W, Telila, Tesfaye, Lerner, Stephen A, Elder, Mahir D, Schreiber, Theodore L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The AngioVac is a vacuum-based device introduced in 2012 to percutaneously remove undesirable material from the intravascular system. In scattered reports, the AngioVac has been used for removal of device-led vegetations and right-sided thrombi. In this article, we describe three cases of right-sided endocarditis treated with AngioVac: a mobile mass extending from the vena cava into the right atrium, large native tricuspid vegetations, and bioprosthetic tricuspid vegetations. This device shows benefit in reducing vegetation load, decreasing septic lung embolization, and reducing reinfection in active intravenous drug users. These cases exhibit the AngioVac's arrival as a new and exciting tool in endocarditis treatment, providing an alternative to open surgery and accessorizing antimicrobial treatment.
ISSN:1479-6678
1744-8298
DOI:10.2217/fca-2016-0076